Hyperfine (NASDAQ:HYPR) Upgraded to “Hold” at Wall Street Zen

Wall Street Zen upgraded shares of Hyperfine (NASDAQ:HYPR – Free Report) from a sell rating to a hold rating in a research report sent to investors on Monday morning,Wall Street Zen reports.

Several other research analysts have also issued reports on the company. B. Riley Financial reaffirmed a “buy” rating and set a $1.60 target price (down from $2.00) on shares of Hyperfine in a research report on Monday, August 10th. Loop Capital set a $2.00 price target on shares of Hyperfine in a report on Tuesday, October 27th. Lucid Cap Mkts started coverage on shares of Hyperfine in a research note on Tuesday, October 27th. They issued a “strong-buy” rating on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Hyperfine in a research report on Thursday, October 15th. Finally, BTIG Research reissued a “buy” rating and issued a $2.00 price objective on shares of Hyperfine in a research note on Tuesday, September 22nd. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $2.02.

Get Our Latest Report on HYPR

Hyperfine Stock Performance

NASDAQ HYPR opened at $0.61 on Monday. The firm’s fifty day moving average price is $0.78 and its two-hundred day moving average price is $1.09. The stock has a market cap of $64.70 million, a PE ratio of -2.03 and a beta of 1.49. Hyperfine has a fifty-two week low of $0.60 and a fifty-two week high of $1.94. The company has a debt-to-equity ratio of 0.42, a quick ratio of 5.45 and a current ratio of 5.10.

Hyperfine (NASDAQ:HYPR – Get Free Report) last issued its quarterly earnings data on Monday, November 9th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.01. Hyperfine had a negative return on equity of 91.18% and a negative net margin of 156.42%. The business had revenue of $5.96 million for the quarter, compared to analyst estimates of $5.84 million. On average, equities analysts expect that Hyperfine will post -0.34 EPS for the current fiscal year.

Institutional Investors Weigh In On Hyperfine

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Russell Investments Group Ltd. lifted its stake in Hyperfine by 7,695.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 487,994 shares of the company’s stock worth $394,000 after purchasing an additional 481,734 shares in the last quarter. Renaissance Technologies LLC increased its stake in Hyperfine by 100.2% in the 1st quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock worth $789,000 after acquiring an additional 365,490 shares during the last quarter. Bank of New York Mellon Corp bought a new position in Hyperfine in the 2nd quarter worth about $419,000. Empowered Funds LLC purchased a new position in shares of Hyperfine during the third quarter worth about $78,000. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Hyperfine by 165.6% during the third quarter. Goldman Sachs Group Inc. now owns 90,917 shares of the company’s stock worth $73,000 after purchasing an additional 56,689 shares in the last quarter. 15.03% of the stock is currently owned by institutional investors.

Hyperfine Company Profile

(Get Free Report)

Hyperfine, Inc. develops portable magnetic resonance imaging (MRI) technology for brain imaging. Its Swoop system is a low-field MRI scanner designed to bring imaging to patients at the point of care, including settings where access to conventional MRI equipment may be limited. The Swoop system is designed for use near a patient’s bedside and does not require a dedicated MRI suite. The U.S. Food and Drug Administration cleared the system in 2020, marking a milestone for the use of portable MRI in clinical care.

Read More

Analyst Recommendations for Hyperfine (NASDAQ:HYPR)

Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.